Article
Integrative transcriptome analysis reveals the molecular events underlying impaired T-cell responses in EGFR-mutant lung cancer.
Scientific reports - 7 Aug 2024
Zhao Yu, Tang Gu, Li Jun, Bian Xiaonan, Zhou Xiaorong, Feng Jian
Abstract excerpt
EGFR mutations are critical oncogenic drivers in lung adenocarcinoma (LUAD). However, the mechanisms by which they impact the tumor microenvironment (TME) and tumor immunity are unclear. Furthermore, the reasons underlying the poor response of EGFR-mutant (EGFR-MU) LUADs to immunotherapy with PD-1/PD-L1 inhibitors are unknown. Utilizing single-cell RNA (sc-RNA) and bulk RNA sequencing datasets, we conducted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
